FDA Approved: DUAKLIR PRESSAIR — Original Application (Covis Pharma US, Inc)

View source ↗

Summary

FDA approved Duaklir Pressair as an original-application fixed-dose inhaled therapy combining aclidinium bromide and formoterol fumarate for chronic obstructive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• DUAKLIR PRESSAIR (ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE)

Snippet

ORIG AP for DUAKLIR PRESSAIR (ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE)